The estimated Net Worth of Michael Paul North is at least $5.81 Milión dollars as of 3 March 2023. Mr. North owns over 5,908 units of Amedisys stock worth over $402,742 and over the last 8 years he sold AMED stock worth over $4,014,596. In addition, he makes $1,391,480 as Chief Information Officer at Amedisys.
Michael has made over 16 trades of the Amedisys stock since 2017, according to the Form 4 filled with the SEC. Most recently he sold 5,908 units of AMED stock worth $510,628 on 3 March 2023.
The largest trade he's ever made was exercising 11,000 units of Amedisys stock on 11 May 2018 worth over $358,160. On average, Michael trades about 3,323 units every 81 days since 2017. As of 3 March 2023 he still owns at least 4,164 units of Amedisys stock.
You can see the complete history of Mr. North stock trades at the bottom of the page.
Michael Paul North serves as Chief Information Officer of the Company since November 2016. He previously served as our Senior Vice President of Operations (from May 11, 2015 to November 3, 2016). Mr. North, a seasoned IT executive, led Amedisys’ successful conversion to the Homecare Homebase platform and plays a significant role in the integration of our acquisitions. Before Amedisys, he served as the Director of Corporate Development Integrations for Humana from May 2006 to May 2015. His senior level responsibilities included all IT and operational integrations for acquisitions. Prior to that, Mr. North served as the Director of IT Support with Kindred Healthcare from October 1999 to May 2006.
As the Chief Information Officer of Amedisys, the total compensation of Michael North at Amedisys is $1,391,480. There are 6 executives at Amedisys getting paid more, with Paul Kusserow having the highest compensation of $12,835,500.
Michael North is 55, he's been the Chief Information Officer of Amedisys since 2016. There are 12 older and 8 younger executives at Amedisys. The oldest executive at Amedisys Inc. is Molly Coye, 72, who is the Independent Director.
Michael's mailing address filed with the SEC is 3854 AMERICAN WAY, SUITE A, , BATON ROUGE, LA, 70816.
Over the last 27 years, insiders at Amedisys have traded over $269,564,877 worth of Amedisys stock and bought 2,690,968 units worth $38,198,016 . The most active insiders traders include Asset Management Llc Kohlbe..., Tide Capital, Llc North Tid... a David Nierenberg. On average, Amedisys executives and independent directors trade stock every 29 days with the average trade being worth of $2,494,602. The most recent stock trade was executed by Richard M Ashworth on 26 December 2023, trading 11,237 units of AMED stock currently worth $896,937.
amedisys is a leading provider of healthcare in the home with a vision of becoming the premiere solution for patients across the country to age in place. from home health to hospice to personal care, amedisys team members provide quality, clinically-distinctive care to more than 376,000 patients every year. every life is precious and tells an incredible story, and we celebrate that each day by honoring our patients with genuine, personal attention. everything we do, from the boardroom to our nationwide network of care centers, is centered on the best care possible for those who have entrusted us with their well-being and comfort. we work closely with doctors and other healthcare providers to coordinate services, and every patient has an individual plan of care that meets their specific needs. amedisys recognizes that nothing we do is possible without our incredible team. for all employees, whether they’re on the front lines delivering direct care or supporting our clinical team, this i
Amedisys executives and other stock owners filed with the SEC include: